[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Si-Bone Inc (SIBN)

Si-Bone Inc (SIBN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Market News and Commentary

SI-BONE Reports Monday: What the Silence on Reimbursement Changes Might Actually Mean

SI-BONE, Inc. (SIBN) reports second-quarter 2026 earnings after the close on August 3, 2026, with analysts expecting continued losses but a narrowing path toward profitability. The medical device company has delivered four consecutive earnings beats, raising the question of whether management can extend that streak while demonstrating progress on its margin expansion and commercial execution initiatives. With the stock trading near recent highs and analyst sentiment turning more bullish, this report will test whether SI-BONE's operational momentum can justify elevated expectations.

SI-BONE, Inc. develops and commercializes minimally invasive surgical implant systems for the sacropelvic anatomy, primarily targeting sacroiliac joint disorders through its proprietary...

Fundamentals

See More
  • Market Capitalization, $K 787,638
  • Shares Outstanding, K 44,349
  • Annual Sales, $ 200,930 K
  • Annual Income, $ -18,900 K
  • EBIT $ -20 M
  • EBITDA $ -17 M
  • 60-Month Beta 0.67
  • Price/Sales 3.97
  • Price/Cash Flow N/A
  • Price/Book 4.45

Options Overview Details

View History
  • Implied Volatility 60.17% (+0.11%)
  • Historical Volatility 40.69%
  • IV Percentile 25%
  • IV Rank 14.06%
  • IV High 167.70% on 03/26/26
  • IV Low 42.57% on 08/14/25
  • Expected Move (DTE 19) 0.61 (3.45%)
  • Put/Call Vol Ratio 0.00
  • Today's Volume 21
  • Volume Avg (30-Day) 205
  • Put/Call OI Ratio 0.13
  • Today's Open Interest 343
  • Open Int (30-Day) 1,230
  • Expected Range 17.15 to 18.37

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 10 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/26
See More
  • Average Estimate $-0.15
  • Number of Estimates 2
  • High Estimate $-0.14
  • Low Estimate $-0.15
  • Prior Year $-0.14
  • Growth Rate Est. (year over year) -7.14%

Price Performance

See More
Period Period Low Period High Performance
1-Month
16.26 +9.23%
on 07/23/26
18.65 -4.77%
on 07/29/26
+1.44 (+8.82%)
since 06/30/26
3-Month
11.48 +54.70%
on 05/11/26
18.65 -4.77%
on 07/29/26
+5.37 (+43.34%)
since 04/30/26
52-Week
11.48 +54.70%
on 05/11/26
21.89 -18.87%
on 01/08/26
-0.04 (-0.22%)
since 07/30/25

Most Recent Stories

More News
SI-BONE Reports Monday: What the Silence on Reimbursement Changes Might Actually Mean

Barchart Research What to Expect from SIBN Earnings SIBN Generated July 31, 2026 Current Price $17.76 EPS Estimate $$-0.15 Consensus Rating Strong Buy Average Move 10.86% SI-BONE Reports Monday: What the...

SIBN : 17.76 (-1.28%)
SI-BONE To Report Second Quarter 2026 Financial Results on August 3, 2026

SANTA CLARA, Calif., July 20, 2026 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), the global leader in developing procedural solutions to address clinical challenges associated with compromised bone,...

SIBN : 17.76 (-1.28%)
SI-BONE To Present at Truist Securities 2026 MedTech Conference on June 16, 2026

SANTA CLARA, Calif., June 04, 2026 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), the global leader in developing procedural solutions to address clinical challenges associated with compromised bone,...

SIBN : 17.76 (-1.28%)
SiBone Q1 Earnings Call Highlights

SiBone (NASDAQ:SIBN) raised its full-year 2026 outlook after reporting double-digit revenue growth in the first quarter, with management pointing to new product launches, expanding physician adoption,...

SIBN : 17.76 (-1.28%)
SI-BONE, Inc. Reports Financial Results for the First Quarter 2026 and Raises 2026 Guidance

First Quarter 2026 Financial Highlights (all comparisons are to the prior year period) Worldwide revenue of $52.6 million, representing growth of 11.2% U.S. revenue of $49.3 million, representing...

SIBN : 17.76 (-1.28%)
SI-BONE: The Breakthrough Device Pipeline Meets Its First Real Deadline

Barchart Research What to Expect from SIBN Earnings SIBN Generated May 8, 2026 Current Price $12.27 EPS Estimate $$-0.17 Consensus Rating Strong Buy Average Move 9.43% SI-BONE: The Breakthrough Device...

SIBN : 17.76 (-1.28%)
SI-BONE: The Breakthrough Device Pipeline Meets Its First Real Deadline

Barchart Research What to Expect from SIBN Earnings SIBN Generated May 8, 2026 Current Price $12.27 EPS Estimate $$-0.17 Consensus Rating Strong Buy Average Move 9.43% SI-BONE: The Breakthrough Device...

SIBN : 17.76 (-1.28%)
SI-BONE: The Breakthrough Device Pipeline Meets Its First Real Deadline

Barchart Research What to Expect from SIBN Earnings SIBN Generated May 8, 2026 Current Price $12.27 EPS Estimate $$-0.17 Consensus Rating Strong Buy Average Move 9.43% SI-BONE: The Breakthrough Device...

SIBN : 17.76 (-1.28%)
SI-BONE To Report First-Quarter 2026 Financial Results on May 11, 2026

SANTA CLARA, Calif., April 20, 2026 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), the global leader in developing procedural solutions to address clinical challenges associated with compromised bone,...

SIBN : 17.76 (-1.28%)
SI-BONE, Inc. Reports Record Financial Results for the Fourth Quarter 2025 and Issues 2026 Guidance

Achieves 20% worldwide revenue growth and positive adjusted EBITDA for Fiscal Year 2025 Generates free cash flow in the Fourth Quarter 2025 SANTA CLARA, Calif., Feb. 23, 2026 (GLOBE NEWSWIRE) -- SI-BONE,...

SIBN : 17.76 (-1.28%)

Business Summary

SI-BONE Inc. is a medical device company which developed the iFuse Implant System(R) for minimally invasive surgical treatment of the sacroiliac joint dysfunction. SI-BONE Inc. is based in Santa Clara, California.

See More

Key Turning Points

3rd Resistance Point 18.96
2nd Resistance Point 18.62
1st Resistance Point 18.19
Last Price 17.76
1st Support Level 17.41
2nd Support Level 17.07
3rd Support Level 16.64

See More

52-Week High 21.89
Fibonacci 61.8% 17.91
Last Price 17.76
Fibonacci 50% 16.68
Fibonacci 38.2% 15.46
52-Week Low 11.48

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.